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1. Introduction 
Vitamin Ds (cholecalciferol) is first hydroxylated 
in the liver to form 2.5-OH-D3 before it is further 
metabolized in the kidney to either l,25(OH)2Ds or 
to 24,25(OH)2Ds and 25 ,26(OH)2Ds, respectively. 
24,25(OH)zDs is the major dihydroxy form of chole- 
calciferol appearing in the plasma of normal rats [ 11. 
It is also found in sizeable quantities in normal man 
and in much smaller amounts or not at all, in anephric 
subjects [2,3]. The stereochemical configuration of 
24,25(OH)*Ds at C-24,24R or 24S, remained unknown 
until the tritiated metabolite was enzymatically gener- 
ated by chick renal homogenates and identified with 
synthetic 24R,25(OH)2Ds by HPL.co-C of their 3,24, 
25-Tris-TMSderivatives [4]. 
Similar identification of 24,25(OH)2Ds from 
human origin was of great interest more especially 
since the determination [5] of the stereochemical con- 
figuration at C-25 of 25,26(OH)*D, isolated from 
human plasma. 
This paper reports the preparation of tritiated 
human 24,25(OH)*Ds and its identification with 
24R,25(OH)zDs in a straight-phase HPLco-C on silica 
of high surface area. 
2. Experimental 
2 .l . Instruments 
Analytical HPLC was effected with a Waters Asso- 
Abbreviations: 25QH-D,, 25hydroxycholecalcifeferol; 
1,25(OH),D,, 1,25dihydroxycholecalciferol; 24,25(OH),D,, 
24,25dihydroxycholecalciferol; 25,26(OH),D,, 25,26dihy- 
droxycholecalciferol; TMS, trimethylsilyl; HPL(co-)C, high 
pressure liquid (co-)chromatopaphy 
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ciates chromatograph equipped with a 254 nm ultra- 
violet detector and a 30 cm X 4 mm i.d. column of 
p Porasil. The mobile phase was dichloromethane 
containing 1% (v/v) methanol at a 1 ml/min flowrate. 
The radioactivity was determined using a toluene 
counting solution containing 0.9% 2,5diphenyloxa- 
zole and 0.02% 1,4-bis [ 2-(4-methyl-5 -phenyloxa- 
zolyl)]-benzene and a liquid scintillation counter 
(Intertechnique model SL 40). 
2.2. Preparation and purification of human radioactive 
Plasma (2.5 1) was obtained during plasmapheresis of 
a patient suffering from macroglobulinaemia. Between 
the 14th and 7th days before donating plasma, the 
patient received 900 IU (22.5 pg) calciferol daily; this 
was to ensure a state of vitamin D repletion, the con- 
dition necessary for formation of 24,25(OH),D [6]. 
On the last day of this pretreatment, when the serum 
level of 25-OH-D was 16.8 ng/ml, the patient was 
given an intraveneous injection of 8 /Ki 25-hydroxy- 
[26,27-3H]cholecalciferol (12 Ci/mmol, Radiochem- 
ical Centre, Amersham) in 1 .O ml ethanol dispersed in 
9 .O ml Intralipid (Vitrum, Stockholm). Plasma was 
collected 7 days later, at which time the concentra- 
tion of 24,25(0H)2 [3H]D3 is maximal [7]. The patient 
consented voluntarily to the procedure after a full 
explanation had been given. 
The plasma was extracted in batches, with chloro- 
form and methanol and was chromatographed on 
columns of Sephadex LH20 eluted with chloroforn- 
n-hexane (13:7, v/v) [S]. Material eluting between 
150-250 ml was collected, the batches were pooled 
and applied to a new column of the same type, from 
which the fraction eluted between 140-200 ml was 
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retained. After evaporation of solvent his fraction 
was purified by HPLC using a column of ZorbaxSIL 
(Du Pont) with 12% isopropanol in n-hexane, at a 
1.5 ml/min flowrate, as mobile phase, The fraction 
eluting between 9 and 10 mm, corresponding tostan- 
dard 24,25(0H)a Da, was collected; the HPLC step 
was repeated and this purified fraction used for iden- 
tification by analytical HPLC (section 2.4). 
2 3. Resolution of a mixture of epimeric 24R, 25 
and 24S,25/UHfiD3 by HPLC 
A mixture of synthetic [8] 24R,25(OH)zDa 
(1.7 gg) and 24&‘,25(OH)2Ds (0.85 gg) was dissolved 
in dichloromethane containing 1% (v/v) methanol and 
injected into the chromatograph. Fig.1 illustrates the 
resolution of the epimers. 
2.4, Co~hromato~aphy with rad~oac~~e hu~n 
In experiments with 24,25(OII),-[26,27-3H]Ds 
from human plasma, the radioactive material was 
added to the above-mentioned mixture of epimeric 
24R25- and 24S,25(OH)zDs and submitted to HPLC. 
Fractions were collected at 1 mln intervals, the sol- 
vent was evaporated, the counting solution was added 
and the radioactivity was determined in each fraction 
(fig.1). 
3. Results and discussion 
Resolution of 24R ,25- and 24S,25(OH)2Da was 
5 l@ 15 20 25 la 55 ,o ,J 5, 15 60 
Tame Cmln.) 
Fig.1. Separationof 24R,25- and 24S,ZS(OH),D, and co-cbro- 
mato~phy of human radioactive 24,25(OH),D, with 24R, 
25(OH),D,.Chromatography wasrealized with 1% methanol- 
dichloromethane. The clear bars represent radioactivity of 
each fraction. O.D. = absorbance at 254 nm. 
performed by HPLC on n Porasil using a mobile 
phase 1% me~~ol-dic~oromethane, The retention 
time was 42 min for the 24R epimer and 45 min for 
the 24s epimer (fig.1). Similar retention time was 
also recorded when injecting the epimers eparately, 
It is noteworthy that as the free form the 24R epimer 
was less polar than the 24s epimer, while with the 
3,24,25-Tris-TMSderivatives thereverse sequence of 
elution has been observed [4] and confirmed by us. 
In experiments with 24,25(0H)2-[26,27-3H]Ds the 
radioactivity clearly migrated with the less polar 
24R,25(OHbDs (fig.1). Recovery of the radioactivity 
was 74%. 
Our experiments demonstrate hat 24,25(OH)zD~ 
from human plasma nd synthetic 24R ,25(OH)zDs 
comigrate by HPLC with a solvent system which 
clearly resolves C-24 epimers. This result establishes 
unequivoc~y that ~o~guration of human 24, 
25(OHhDa is 24R and is identical with that found 
for biosynthetically generated 24,25(0H)~Da 141. 
It should be emphasised that in the case of 25, 
26(OH)*De, another dihydroxy metabolite of vitamin 
Da found in man, the con~guration at C-25 was deter- 
mined [5] as 25s for material of both human and bio- 
synthetic origin. 
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